A gene-expression study [152] noted that high ATP2C2-expression was associated with worsened patient survival in OSCC, breast cancer, thyroid carcinoma, head-and-neck squamous cell carcinoma, kidney, renal clear cell carcinoma, and lung squamous cell carcinoma [152]. Here, ATP2C2 is linked to squamous cell lung carcinoma.